Iron Chelation Therapy.

Area of Science:

• Hematology
• Toxicology
• Pharmacology

Background:

• Iron overload is a severe complication in transfusion-dependent anemias and ineffective erythropoiesis.
• Excess iron accumulation leads to serious organ damage, including heart failure, liver cirrhosis, and endocrine abnormalities.

Purpose of the Study:

• To review iron overload complications and current chelation therapy options.
• To highlight the importance of adherence in successful iron chelation treatment.

Main Methods:

• Review of available iron chelators: parenteral deferoxamine and oral deferiprone and deferasirox.
• Discussion of dose adjustment strategies to prevent over-chelation.
• Exploration of factors influencing patient adherence to lifelong treatment.

Main Results:

• Three main iron chelators are available, each with specific administration routes and considerations.
• Effective iron chelation requires careful monitoring and dose adjustments.
• Adherence is influenced by chelator convenience, tolerability, and psychosocial support.

Conclusions:

• Iron chelation therapy is essential for managing iron overload in specific anemias.
• Optimizing treatment outcomes depends on balancing efficacy with patient adherence.
• A multidisciplinary approach supporting patient well-being is vital for long-term management.